TrialJNCI cancer spectrum2025

Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial.

Heinz-Josef Lenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.